menu
    • menu

    Company profile for American Gene Technologies

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AGT uses a proprietary gene delivery platform to rapidly develop patented gene and cell therapies that cure infectious disease, monogenic disorders, and cancers by targeting their genetic root causes. AGT is developing and commercializing genetic medicines targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma (liver cancer, or HCC). Our drug candidates have achieved initial proof of c...
    AGT uses a proprietary gene delivery platform to rapidly develop patented gene and cell therapies that cure infectious disease, monogenic disorders, and cancers by targeting their genetic root causes. AGT is developing and commercializing genetic medicines targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma (liver cancer, or HCC). Our drug candidates have achieved initial proof of concept in preclinical studies and have potential to deliver cost-effective therapies that are better targeted and more potent with fewer side effects. AGT’s drugs will treat symptomatic disease.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    American Gene TechnologiesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    9640 Medical Center Dr, Rockville, MD 20850
    Telephone
    Telephone
    (301) 337-2100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.americangene.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/american-gene-technologies-international-inc
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/americangene?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    HIV gene therapy biotech takes SPAC street
    HIV gene therapy biotech takes SPAC street

    10 Aug 2023

    // Gabrielle Masson FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/spac-future-gene-therapy-biotech-reimagining-hiv-treatment-takes-blank-check-route

    Gabrielle Masson FIERCE BIOTECH
    10 Aug 2023
    Share Share
    HIV Cure Program Releases Initial Clinical Trial Data
    HIV Cure Program Releases Initial Clinical Trial Data

    15 Jul 2021

    // GLOBE NEWSWIRE

    https://www.globenewswire.com/news-release/2021/07/16/2264067/0/en/HIV-Cure-Program-Releases-Initial-Clinical-Trial-Data.html

    GLOBE NEWSWIRE
    15 Jul 2021
    Share Share
    American Gene Technologies Announces First Trial in Ph1 Study of AGT103
    American Gene Technologies Announces First Trial in Ph1 Study of AGT103

    10 Nov 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/11/10/2123943/0/en/American-Gene-Technologies-Announces-First-Trial-Participant-Enrolled-in-Phase-1-Study-of-AGT103-T-Against-HIV.html

    GLOBENEWSWIRE
    10 Nov 2020
    Share Share
    Design-Based Development Paradigm for Cell/Gene Therapies Will Significantly
    Design-Based Development Paradigm for Cell/Gene Therapies Will Significantly

    27 Aug 2020

    // IPQ

    https://www.ipqpubs.com/2020/08/27/design-based-development-paradigm-for-cell-gene-therapies-will-significantly-reduce-costs-timelines-and-regulatory-concerns-agt-ceo-galvin-maintains/

    IPQ
    27 Aug 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search